Home

Brawn Biotech Ltd Quarterly Result

Image

Brawn Biotech Ltd

NSE: BRAWNBIOTECH

Net Profit - Last Quarter

₹ -0.04 Cr.

Last updated on: Jan 23, 2025

Brawn Biotech Ltd Quarterly Results Key Highlights

  • The revenue of Brawn Biotech Ltd for the Jun '23 is ₹ 0.12 crore as compare to the revenue of ₹ 0 crore.
  • This represent the growth of 9.2233718E16%a1# The ebitda of Brawn Biotech Ltd for the Jun '23 is ₹ -0.04 crore as compare to the ebitda of ₹ 0 crore.
  • This represent the decline of -9.2233718E16%a1#The net profit of Brawn Biotech Ltd changed from ₹ -0.04 crore to ₹ -0.04 crore over 1 quarters.
  • This represents a CAGR of 0.00% a1#.

Brawn Biotech Ltd Quarterly Results Analysis

Market Price of Brawn Biotech Ltd

1M

1Y

3Y

5Y

Monitoring Brawn Biotech Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Jan 202519.76
20 Jan 202520.75
17 Jan 202521.77
16 Jan 202522.9
15 Jan 202524.09
14 Jan 202525.35
13 Jan 202525.4
10 Jan 202524.42
09 Jan 202523.26
07 Jan 202524

Revenue

No data available

* All values are in ₹ crore

EBITDA

No data available

* All values are in ₹ crore

Net Profit

No data available

* All values are in ₹ crore

Brawn Biotech Ltd News Hub

Brawn Biotech reports standalone net loss of Rs 0.53 crore in the June 2024 quarter

Net Loss of Brawn Biotech reported to Rs 0.53 crore in the quarter ended June 2024 as against net lo

Read more

14 Aug 24

Brawn Biotech to discuss results

Brawn Biotech will hold a meeting of the Board of Directors of the Company on 14 August 2024. Powere

Read more

12 Aug 24

Brawn Biotech to conduct AGM

Brawn Biotech announced that the 39th Annual General Meeting (AGM) of the company will be held on 30

Read more

05 Sept 24

Brawn Biotech to conduct board meeting

Brawn Biotech will hold a meeting of the Board of Directors of the Company on 14 November 2024 Power

Read more

11 Nov 24

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Quarterly Results of Brawn Biotech Ltd

What key financial metrics are included in Brawn Biotech Ltd's quarterly results?

Key financial metrics in Brawn Biotech Ltd's quarterly results typically include revenue, net profit, earnings per share (EPS), and operating margins. Other metrics might include cash flow, operating expenses, and client metrics.

When does Brawn Biotech Ltd announce its quarterly results?

Brawn Biotech Ltd usually announces its quarterly results around mid-July for Q1, mid-October for Q2, mid-January for Q3, and mid-April for Q4, aligning with the end of each fiscal quarter. However, different finance companies have their respective schedules for announcing their quarterly results.

How does Brawn Biotech Ltd's quarterly performance impact its stock price?

Brawn Biotech Ltd's quarterly performance can lead to stock price volatility, with strong results often driving the price up, while disappointing results can cause it to drop. Investor sentiment and market expectations also play significant roles.

What is the impact of Brawn Biotech Ltd's quarterly results on dividends?

The impact of Brawn Biotech Ltd's quarterly results on dividends can influence dividend decisions, with strong performance potentially leading to increased or special dividends, while weaker results might result in stable or reduced dividends.

Are there any special announcements usually made during Brawn Biotech Ltd's quarterly results?

Yes, Brawn Biotech Ltd often makes special announcements during its quarterly results, including strategic updates, key client wins, and major contract renewals. They might also guide future performance and share insights on industry trends. These updates are typically highlighted in their press release. However, special announcements made during quarterly results may vary from company to company.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions